Is it safe to treat allogeneic stem cell transplanted recipients at home during the pancytopenic phase? A pilot trial. [electronic resource]
Producer: 20040517Description: 474-8 p. digitalISSN:- 0755-4982
- Adolescent
- Adult
- Ambulatory Care -- statistics & numerical data
- Antineoplastic Agents -- adverse effects
- Bone Marrow Purging -- adverse effects
- Cross Infection -- epidemiology
- Female
- Fever of Unknown Origin -- epidemiology
- Follow-Up Studies
- Hematologic Neoplasms -- drug therapy
- Home Care Services, Hospital-Based -- statistics & numerical data
- Humans
- Length of Stay -- statistics & numerical data
- Male
- Middle Aged
- Neutropenia -- chemically induced
- Opportunistic Infections -- epidemiology
- Outcome and Process Assessment, Health Care -- statistics & numerical data
- Pancytopenia -- chemically induced
- Patient Isolation -- statistics & numerical data
- Patient Readmission -- statistics & numerical data
- Pilot Projects
- Risk Factors
- Stem Cell Transplantation
- Switzerland
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.